vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and SFL Corp Ltd. (SFL). Click either name above to swap in a different company.
SFL Corp Ltd. is the larger business by last-quarter revenue ($353.7M vs $207.8M, roughly 1.7× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 1.1%, a 56.2% gap on every dollar of revenue.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
SFL Corp Ltd is a global maritime transportation and vessel owning enterprise with a diversified fleet including container ships, oil tankers, dry bulk carriers and offshore support vessels. It serves international logistics, energy and bulk commodity sectors, offering long-term and spot charter services to clients across major global trade routes.
IDYA vs SFL — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $353.7M |
| Net Profit | $119.2M | $4.0M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | 22.8% |
| Net Margin | 57.4% | 1.1% |
| Revenue YoY | — | -27.0% |
| Net Profit YoY | 330.1% | -93.9% |
| EPS (diluted) | $1.33 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $353.7M | ||
| Q3 25 | $207.8M | — | ||
| Q4 24 | — | $484.4M | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $0 | — | ||
| Q4 23 | — | $414.5M | ||
| Q4 22 | — | $364.7M |
| Q4 25 | — | $4.0M | ||
| Q3 25 | $119.2M | — | ||
| Q4 24 | — | $64.7M | ||
| Q3 24 | $-51.8M | — | ||
| Q2 24 | $-52.8M | — | ||
| Q1 24 | $-39.6M | — | ||
| Q4 23 | — | $60.7M | ||
| Q4 22 | — | $98.3M |
| Q4 25 | — | 22.8% | ||
| Q3 25 | 52.2% | — | ||
| Q4 24 | — | 32.8% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 33.4% | ||
| Q4 22 | — | 38.3% |
| Q4 25 | — | 1.1% | ||
| Q3 25 | 57.4% | — | ||
| Q4 24 | — | 13.4% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 14.6% | ||
| Q4 22 | — | 27.0% |
| Q4 25 | — | $0.03 | ||
| Q3 25 | $1.33 | — | ||
| Q4 24 | — | $0.49 | ||
| Q3 24 | $-0.60 | — | ||
| Q2 24 | $-0.68 | — | ||
| Q1 24 | $-0.53 | — | ||
| Q4 23 | — | $0.48 | ||
| Q4 22 | — | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $150.8M |
| Total DebtLower is stronger | — | $2.6B |
| Stockholders' EquityBook value | $1.1B | $960.9M |
| Total Assets | $1.2B | $3.6B |
| Debt / EquityLower = less leverage | — | 2.69× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $150.8M | ||
| Q3 25 | $786.9M | — | ||
| Q4 24 | — | $134.6M | ||
| Q3 24 | $920.0M | — | ||
| Q2 24 | $701.7M | — | ||
| Q1 24 | $698.8M | — | ||
| Q4 23 | — | $165.5M | ||
| Q4 22 | — | $188.4M |
| Q4 25 | — | $2.6B | ||
| Q3 25 | — | — | ||
| Q4 24 | — | $2.9B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | $2.2B | ||
| Q4 22 | — | $2.2B |
| Q4 25 | — | $960.9M | ||
| Q3 25 | $1.1B | — | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $931.7M | — | ||
| Q1 24 | $935.3M | — | ||
| Q4 23 | — | $1.0B | ||
| Q4 22 | — | $1.1B |
| Q4 25 | — | $3.6B | ||
| Q3 25 | $1.2B | — | ||
| Q4 24 | — | $4.1B | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $973.7M | — | ||
| Q1 24 | $961.5M | — | ||
| Q4 23 | — | $3.7B | ||
| Q4 22 | — | $3.9B |
| Q4 25 | — | 2.69× | ||
| Q3 25 | — | — | ||
| Q4 24 | — | 2.54× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 2.08× | ||
| Q4 22 | — | 2.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $118.4M |
| Free Cash FlowOCF − Capex | $142.2M | — |
| FCF MarginFCF / Revenue | 68.4% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 1.19× | 29.75× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $118.4M | ||
| Q3 25 | $142.2M | — | ||
| Q4 24 | — | $182.4M | ||
| Q3 24 | $-49.2M | — | ||
| Q2 24 | $-32.9M | — | ||
| Q1 24 | $-43.8M | — | ||
| Q4 23 | — | $112.1M | ||
| Q4 22 | — | $188.4M |
| Q4 25 | — | — | ||
| Q3 25 | $142.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-49.7M | — | ||
| Q2 24 | $-33.9M | — | ||
| Q1 24 | $-45.1M | — | ||
| Q4 23 | — | — | ||
| Q4 22 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 68.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q4 22 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q4 22 | — | — |
| Q4 25 | — | 29.75× | ||
| Q3 25 | 1.19× | — | ||
| Q4 24 | — | 2.82× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 1.85× | ||
| Q4 22 | — | 1.92× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
